From time to time, Insurers can do a particularly good job of communicating a particular strategy or educating plan sponsors on a particular topic. This month (April 2016) Green Shield Canada came out with a very good document outlining their position and possibly that of their competitors with respect to the treatment of "generic" or [...]
This was a reporters take on a seminar presentation by Chris Pryce made at the Bellagio Event Venue (March 2nd, 2016) in front of an audience of some 200 plus Advisors, Consultants, Pharmaceutical and Third Party Administrators. In the News - March 3, 2016 (Benefits and Pension Monitor) http://www.bpmmagazine.com/benefits_news.php Advisors need to dare to be different [...]
Over the last two years, there has been a significant change to the pharmaceutical benefits landscape due to an increase in specialty drugs entering the market. Although they impact approximately only 2% of claimants, the number of specialty drugs is growing and they contribute significantly to the share of total drug cost under an employee [...]
The Canada Revenue Agency (CRA) has confirmed that, under the right circumstances, cannabis now qualifies as an allowable medical expense under the Income Tax Act. The Canadian Medical Cannabis Industry Association(CMCIA) says it has received a letter from the CRA which confirms that medical cannabis purchased from a licensed producer is an allowable medical expense [...]
The Express Script report is 86 pages and although it makes for great reading, the skinny essentials were noted on the 1st couple of pages of the report (excerpted below): Executive Summary / Trends and a Glance According to the Express Script report, prescription drugs play an important and increasingly essential role in reducing the impact [...]
